Antibody-mediated Rejection Market is segmented By Treatment (Plasma Exchange, IVIG, Complement Inhibitors, Proteasome Inhibitors), By Drugs in Development (Clazakizumab, Imlifidase), By Therapeutic Approach (Monoclonal Antibodies, Complement Inhibitors), By Patient Type (Pre-sensitized Transplant Recipients, Acute AMR Patients), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD million) for the above-mentioned.(2025-2032)
Excel Databook (Quantitative Data Only)
$2,000
Two thousand two hundred dollars
PDF Report and Excel Databook (Both)
Single User License
(1 User)
$4,500
$3,000
Three thousand two hundred fifty dollars
Frequently Purchased
PDF Report and Excel Databook (Both)
Multi User License
(up to 7 Users)
$7,000
$5,000
Five thousand two hundred fifty dollars
PDF Report and Excel Databook (Both)
Corporate User License
(Unlimited Users)
$10,000
$6,000
Six thousand seven hundred fifty dollars